New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease

  • 1.

    Hyman, B. T. et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 8, 1–13 (2012).

  • 2.

    McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011).

  • 3.

    Dubois, B. et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 13, 614–629 (2014).

  • 4.

    Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).

  • 5.

    Mattsson, N. et al. Revolutionizing Alzheimer’s disease and clinical trials through biomarkers. Alzheimers Dement. 1, 412–419 (2015).

  • 6.

    Bateman, R. J. et…

  • Read more…